Inovio Pharma (INO) Tops Q4 EPS by 6c, Beats on Revenues
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.19 -1.65%
EPS Growth %: +75.9%
Financial Fact:
Net loss/ (gain) attributable to non-controlling interest: 0
Today's EPS Names:
OCCI, IPX, ALZN, More
EPS Growth %: +75.9%
Financial Fact:
Net loss/ (gain) attributable to non-controlling interest: 0
Today's EPS Names:
OCCI, IPX, ALZN, More
Join SI Premium – FREE
Note: EPS may not be comparable
Inovio Pharma (NASDAQ: INO) reported Q4 EPS of ($0.24), $0.06 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $8.8 million versus the consensus estimate of $7.53 million.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
- Stitch Fix (SFIX) Tops Q4 EPS by 4c; Offers Guidance
- Costco Wholesale (COST) PT Raised to $1,040 at DA Davidson Following Q4 Earnings
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
